Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve
Jawitz, Oliver K., Wang, Tracy Y., Lopes, Renato D., Chavez, Alma, Boyer, Brittanny, Kim, Hwasoon, Anstrom, Kevin J., Becker, Richard C., Blackstone, Eugene, Ruel, Marc, Thourani, Vinod H., Puskas, John D., Gerdisch, Marc W., Johnston, Douglas, Capps, Scott, Alexander, John H., Svensson, Lars G.
Published in The American heart journal (01.09.2020)
Published in The American heart journal (01.09.2020)
Get full text
Journal Article
Rationale and design of PROACT Xa: a randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban vs. warfarin in patients with a mechanical On-X® Aortic Heart Valve
Jawitz, Oliver K., Wang, Tracy Y., Lopes, Renato D., Chavez, Alma, Boyer, Brittanny, Kim, Hwasoon, Anstrom, Kevin J., Becker, Richard C., Blackstone, Eugene, Ruel, Marc, Thourani, Vinod H., Puskas, John D., Gerdisch, Marc W., Johnston, Douglas, Capps, Scott, Alexander, John H., Svensson, Lars G.
Published in The American heart journal (25.06.2020)
Published in The American heart journal (25.06.2020)
Get full text
Journal Article